Companies race to commercialize cancer blood screenings, but effectiveness is an open question

With advances in DNA sequencing and data science making the blood tests possible, Menlo Park-based Grail and other companies are racing to commercialize them.

Related Keywords

Japan ,United States ,Oregon ,United Kingdom ,White House ,District Of Columbia ,Britain ,American ,Barry Kramer ,Lori Minasian ,Britain National Health Service ,National Cancer Institute ,Lisa Schwartz Foundation For Truth ,Drug Administration ,National Cancer Institute Division Of Prevention ,Joyce Ares ,Menlo Park Based Grail ,Lisa Schwartz Foundation ,Tomasz Beer ,Oregon Health ,Science University ,National Health Service ,